<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01959711</url>
  </required_header>
  <id_info>
    <org_study_id>BBN 501/ZKL/130/L</org_study_id>
    <nct_id>NCT01959711</nct_id>
  </id_info>
  <brief_title>Randomized Clinical Trial of Posterior Retroperitoneoscopic Adrenalectomy Versus Lateral Laparoscopic Adrenalectomy</brief_title>
  <official_title>Randomized Clinical Trial of Posterior Retroperitoneoscopic Adrenalectomy Versus Lateral Transperitoneal Laparoscopic Adrenalectomy With a Five-year Follow-up</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jagiellonian University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jagiellonian University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Laparoscopic adrenalectomy has become the gold standard operation for non-malignant adrenal
      tumors replacing open adrenalectomy. The most popular lateral transperitoneal laparoscopic
      adrenalectomy (LTLA) approach has been recently challenged by an increasing popularity of the
      posterior retroperitoneoscopic adrenalectomy (PRA) approach which is believed by many
      surgeons as an easy to learn, reproducible and beneficial for patients. However, this belief
      is not evidence-based, so far. The aim of this study is to clarify if PRA is superior to the
      LTLA as minimally invasive approach to small and benign adrenal tumors.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Laparoscopic adrenalectomy has replaced open adrenalectomy as the standard operation for
      non-malignant adrenal tumours. Thanks to the popularization of the posterior technique
      described by Walz and co-workers, the posterior retroperitoneal adrenalectomy (PRA) is being
      performed in increasing numbers worldwide. Advocates for the laparoscopic and
      retroperitoneoscopic approaches cite the advantages of each technique, but there is no
      published evidence that supports the superiority of one over the other. Most of the published
      literature is retrospective, with inadequate or no controls and with potential biases.

      The aim of this study is to test the hypothesis that PRA is superior to the lateral
      transperitoneal laparoscopic adrenalectomy (LTLA) as minimally invasive approach to small and
      benign adrenal tumors.

      For a sample size calculation an assumption was made that a 20% reduction in duration of
      surgery represents clinically relevant difference. To detect this, it was calculated that 24
      patients would be required in each treatment arm to give the study a power of 90 per cent.
      Anticipating a 25% loss to follow-up, 32 patients per arm were required in the study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2006</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">June 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>duration of surgery</measure>
    <time_frame>intraoperatively</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative recovery</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 7 days</time_frame>
    <description>including: postoperative pain, length of hospital stay, time to oral intake, time to ambulation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood loss</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative complications</measure>
    <time_frame>up to 5 years after surgery</time_frame>
    <description>including: pneumothorax/haemothorax, surgical emphysema, chest infection, visceral injury, peritonitis/abscess, wound infection, neuralgia, and surgical access site herniation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">65</enrollment>
  <condition>Adrenal Tumor</condition>
  <condition>Pheochromocytoma</condition>
  <condition>Conn's Syndrome</condition>
  <condition>Cushing's Syndrome</condition>
  <arm_group>
    <arm_group_label>Posterior RA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Posterior retroperitoneoscopic adrenalectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lateral transperitoneal LA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lateral transperitoneal laparoscopic adrenalectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Posterior RA</intervention_name>
    <description>Posterior retroperitoneoscopic adrenalectomy</description>
    <arm_group_label>Posterior RA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Lateral transperitoneal LA</intervention_name>
    <description>Lateral transperitoneal laparoscopic adrenalectomy</description>
    <arm_group_label>Lateral transperitoneal LA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  unilateral adrenal tumor below 7cm in diameter without suspicion for malignancy

        Exclusion Criteria:

          -  active malignancy

          -  pregnancy or lactation

          -  age below 18 years, or above 80 years

          -  high-risk patients according to the American Society of Anesthesiology (ASA 4 grade or
             higher

          -  inability to comply with the scheduled follow-up protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marcin Barczyński, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jagiellonian University Medical College</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jagiellonian University, Medical College, Third Chair of General Surgery</name>
      <address>
        <city>Kraków</city>
        <zip>31-202</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <reference>
    <citation>Barczyński M, Konturek A, Gołkowski F, Cichoń S, Huszno B, Peitgen K, Walz MK. Posterior retroperitoneoscopic adrenalectomy: a comparison between the initial experience in the invention phase and introductory phase of the new surgical technique. World J Surg. 2007 Jan;31(1):65-71.</citation>
    <PMID>17180554</PMID>
  </reference>
  <reference>
    <citation>Lee CR, Walz MK, Park S, Park JH, Jeong JS, Lee SH, Kang SW, Jeong JJ, Nam KH, Chung WY, Park CS. A comparative study of the transperitoneal and posterior retroperitoneal approaches for laparoscopic adrenalectomy for adrenal tumors. Ann Surg Oncol. 2012 Aug;19(8):2629-34. doi: 10.1245/s10434-012-2352-0. Epub 2012 Apr 20.</citation>
    <PMID>22526902</PMID>
  </reference>
  <reference>
    <citation>Perrier ND, Kennamer DL, Bao R, Jimenez C, Grubbs EG, Lee JE, Evans DB. Posterior retroperitoneoscopic adrenalectomy: preferred technique for removal of benign tumors and isolated metastases. Ann Surg. 2008 Oct;248(4):666-74. doi: 10.1097/SLA.0b013e31818a1d2a.</citation>
    <PMID>18936580</PMID>
  </reference>
  <reference>
    <citation>Walz MK, Alesina PF, Wenger FA, Deligiannis A, Szuczik E, Petersenn S, Ommer A, Groeben H, Peitgen K, Janssen OE, Philipp T, Neumann HP, Schmid KW, Mann K. Posterior retroperitoneoscopic adrenalectomy--results of 560 procedures in 520 patients. Surgery. 2006 Dec;140(6):943-8; discussion 948-50.</citation>
    <PMID>17188142</PMID>
  </reference>
  <reference>
    <citation>Constantinides VA, Christakis I, Touska P, Palazzo FF. Systematic review and meta-analysis of retroperitoneoscopic versus laparoscopic adrenalectomy. Br J Surg. 2012 Dec;99(12):1639-48. doi: 10.1002/bjs.8921. Epub 2012 Sep 28. Review.</citation>
    <PMID>23023976</PMID>
  </reference>
  <reference>
    <citation>Rubinstein M, Gill IS, Aron M, Kilciler M, Meraney AM, Finelli A, Moinzadeh A, Ukimura O, Desai MM, Kaouk J, Bravo E. Prospective, randomized comparison of transperitoneal versus retroperitoneal laparoscopic adrenalectomy. J Urol. 2005 Aug;174(2):442-5; discussion 445.</citation>
    <PMID>16006861</PMID>
  </reference>
  <verification_date>October 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 6, 2013</study_first_submitted>
  <study_first_submitted_qc>October 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 10, 2013</study_first_posted>
  <last_update_submitted>October 8, 2013</last_update_submitted>
  <last_update_submitted_qc>October 8, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 10, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Jagiellonian University</investigator_affiliation>
    <investigator_full_name>Marcin Barczynski</investigator_full_name>
    <investigator_title>Associate Professor of Surgery at the Third Chair of General Surgery</investigator_title>
  </responsible_party>
  <keyword>Lateral transperitoneal laparoscopic adrenalectomy</keyword>
  <keyword>Posterior retroperitoneoscopic adrenalectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Pheochromocytoma</mesh_term>
    <mesh_term>Cushing Syndrome</mesh_term>
    <mesh_term>Adrenal Gland Neoplasms</mesh_term>
    <mesh_term>Hyperaldosteronism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

